Evaluation of Neuromuscular Disease
NCT00001201 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2008-03-04
Summary
The peripheral nervous system is the portion of the nervous system outside of the brain and spinal cord. It includes the 12 pairs of cranial nerves, 31 pairs of spinal nerves and their branches, nerves responsible for sensation and maintenance of normal body functions (sympathetic and parasympathetic nerves).
Years of research using clinical examinations, microscopic examinations, and electrophysiology have made the peripheral nervous system the best-studied and most available portion of the nervous system. However, even with all of the extensive studies conducted on the peripheral nervous system, many conditions remain unclassified.
The EMG Laboratory at the NIH concentrates on studying disorders of the peripheral nervous system. This protocol was designed to allow the EMG Laboratory to;
I) Learn more about established diseases of the peripheral nervous system
II) Identify and characterize new diseases of the peripheral nervous system
III) Assess current techniques in the diagnosis of diseases of the peripheral nervous system
IV) Refine old methods and develop new ones for the diagnosis of diseases of the peripheral nervous system.
Conditions
- Healthy
- Neuromuscular Disease
- Peripheral Nervous System Disease
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1984-10-31
- Completion
- 2002-11-30
Countries
- United States
Study Locations
More Related Trials
-
Evaluate the Safety and Efficacy of a Peripheral Nerve Stimulation
NCT05827848 ·Status: RECRUITING ·Phase: NA
-
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 ·Status: UNKNOWN ·Phase: NA
-
Efficacy Study of Botox to Treat Neuropathic Pain
NCT00527202 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Efficacy of Lithium Carbonate in Spinal Cord Injury Patients With Neuropathic Pain
NCT01855594 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Physiological Measures as Determinants of Pain Risk
NCT02985294 ·Status: UNKNOWN
-
Preferences in Pain Treatment: A Discrete Choice Experiment in Patients With Peripheral Neuropathic Pain (pNP)
NCT04184596 ·Status: COMPLETED
-
Reference Values of Intraepidermal Nerve Fiber Density in Children and Small Fiber Neuropathy in Neurodevelopmental Disorders
NCT05645874 ·Status: COMPLETED
-
Pain-related Evoked Potentials in Unilateral Peripheral Nerve Injuries
NCT03082820 ·Status: COMPLETED
-
Economic Medical Evaluation of Treatment of the Neuropathic Pain Rebel by Cortical Stimulation
NCT00241566 ·Status: COMPLETED ·Phase: PHASE4
-
Interaction Between NGF and Acute Exercise-induced Ischemia
NCT03470038 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluation of the Safety and Efficacy of N-desmethylclobazam in Patients With Peripheral Neuropathic Pain
NCT04480164 ·Status: SUSPENDED ·Phase: PHASE2
-
Analysis of Cortical Excitability in Neuropathic Pain
NCT00789347 ·Status: UNKNOWN
-
Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer
NCT00281853 ·Status: COMPLETED
-
Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy
NCT05935956 ·Status: COMPLETED
-
Abdominal Cutaneous Nerve Entrapment Syndrome
NCT03574727 ·Status: COMPLETED
-
Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
NCT01655849 ·Status: COMPLETED ·Phase: PHASE2
-
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
NCT06052631 ·Status: RECRUITING
-
Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy
NCT06389721 ·Status: RECRUITING
-
Impact of Oral Magnesium on Neuropathic Pain
NCT01121653 ·Status: COMPLETED ·Phase: PHASE4
-
Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia
NCT04533919 ·Status: WITHDRAWN
-
Dextromethorphan Versus Placebo for Neuropathic Pain
NCT00001344 ·Status: COMPLETED ·Phase: PHASE2
-
The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
NCT02666456 ·Status: UNKNOWN
-
Evaluation of Injection Techniques in Celiac Plexus Neurolysis
NCT02068677 ·Status: COMPLETED ·Phase: NA
-
Objective Assessment of Sensory Nerve Fiber Sensitivity
NCT03596489 ·Status: COMPLETED
-
NTX-001 to Repair Peripheral Nerve Transection(s)
NCT05565846 ·Status: AVAILABLE